SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹26,449 Cr | ₹19,956 Cr | ₹17,656 Cr | ₹14,296 Cr | ₹15,948 Cr |
What is the latest Net Current Assets ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹26,449 Cr |
Mar2023 | ₹19,956 Cr |
Mar2022 | ₹17,656 Cr |
Mar2021 | ₹14,296 Cr |
Mar2020 | ₹15,948 Cr |
How is Net Current Assets of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹26,449 Cr | 32.54 | |
Mar2023 | ₹19,956 Cr | 13.02 | |
Mar2022 | ₹17,656 Cr | 23.50 | |
Mar2021 | ₹14,296 Cr | -10.35 | |
Mar2020 | ₹15,948 Cr | - |
Compare Net Current Assets of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹422,264.8 Cr | -0.9% | -4.8% | 50.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,183.0 Cr | 3% | 5.9% | 65% | Stock Analytics | |
CIPLA | ₹120,605.0 Cr | 1.5% | 0.1% | 19.9% | Stock Analytics | |
MANKIND PHARMA | ₹103,515.0 Cr | 0.6% | 3.1% | 34.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,869.0 Cr | -0.4% | -8.2% | 7.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,808.6 Cr | 0.6% | -5.3% | 51% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | -0.9% |
-4.8% |
50.2% |
SENSEX | 3.5% |
-0.1% |
21.9% |
You may also like the below Video Courses